Concepedia

Conor Knightly

CK

Statistics

Publications

5

Citations

272

H-Index

5

Active since

2009

Affiliations

Moderna Therapeutics (United States)(Current)

Meridian Clinical Research

Optimal Solutions (United States)

Conor Knightly is an author at Moderna Therapeutics (United States) specializing in viral vaccines, immunology, and immunization.

Publications per year

2009–2024

5

Publications

5

Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults

Allison August, Christine A. Shaw, Heather Lee et al. · Open Forum Infectious Diseases · 2022 · 83 citations · Full text

, , +17

PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDREN

Margarita Gomez, Maurice A. Mufson, Filip Dubovsky et al. · The Pediatric Infectious Disease Journal · 2009 · 70 citations

, , +17

Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial

Carlos Fierro, Daniel C. Brune, Marian Shaw et al. · The Journal of Infectious Diseases · 2024 · 58 citations · Full text

, , +16

A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults

Christine A. Shaw, Allison August, Stephan Bart et al. · Vaccine · 2023 · 40 citations

, , +11

2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Against hMPV and PIV3

Christine A. Shaw, Heather Lee, Conor Knightly et al. · Open Forum Infectious Diseases · 2019 · 21 citations · Full text

, , +17

1–5 of 5